Dr. Maria Orellana-Matta, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $500.00 | 1 | 51.4% |
| Food and Beverage | $471.92 | 7 | 48.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Promius Pharma LLC | $619.95 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $218.75 | 3 | $0 (2023) |
| Indivior Inc. | $100.00 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $18.70 | 1 | $0 (2022) |
| Novo Nordisk Inc | $14.52 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.83 | 1 | Gilead Sciences, Inc. ($28.83) |
| 2022 | $208.62 | 3 | Gilead Sciences, Inc. ($189.92) |
| 2021 | $14.52 | 1 | Novo Nordisk Inc ($14.52) |
| 2020 | $100.00 | 1 | Indivior Inc. ($100.00) |
| 2017 | $619.95 | 2 | Promius Pharma LLC ($619.95) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.83 | General |
| 07/28/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $99.92 | General |
| Category: HCV | ||||||
| 04/19/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: HCV | ||||||
| 02/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OUD | ||||||
| 11/29/2017 | Promius Pharma LLC | Zembrace (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Neurology | ||||||
| 11/29/2017 | Promius Pharma LLC | Zembrace (Drug) | Food and Beverage | Cash or cash equivalent | $119.95 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 83 | 120 | $26,479 | $7,978 |
| 2022 | 4 | 82 | 117 | $26,773 | $7,829 |
| 2021 | 3 | 60 | 69 | $18,708 | $5,233 |
| 2020 | 5 | 140 | 174 | $32,142 | $7,830 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 63 | $15,160 | $3,736 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $5,619 | $2,910 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 34 | $5,699 | $1,333 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 70 | $16,845 | $4,727 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,688 | $1,276 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,721 | $991.60 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 21 | $3,520 | $834.46 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 45 | $11,075 | $2,423 | 21.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $4,642 | $1,557 | 33.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,990 | $1,253 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 24 | 24 | $9,493 | $2,711 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 68 | $16,278 | $2,171 | 13.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 26 | 31 | $2,397 | $1,518 | 63.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 29 | 37 | $2,043 | $1,204 | 58.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 14 | $1,931 | $224.29 | 11.6% |
About Dr. Maria Orellana-Matta, M.D
Dr. Maria Orellana-Matta, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1245650308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Orellana-Matta, M.D has received a total of $971.92 in payments from pharmaceutical and medical device companies, with $28.83 received in 2023. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($500.00).
As a Medicare-enrolled provider, Orellana-Matta has provided services to 365 Medicare beneficiaries, totaling 480 services with total Medicare billing of $28,870. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Buffalo, NY
- Active Since 04/16/2014
- Last Updated 05/18/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1245650308
Products in Payments
- Zembrace (Drug) $619.95
- Epclusa (Drug) $189.92
- SUBLOCADE (Drug) $100.00
- ENTRESTO (Drug) $18.70
- RYBELSUS (Drug) $14.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Buffalo
Sandra Sieminski, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $64,808
Carter Lindborg, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $40,328
Dr. Thomas Suchy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,872
Paola Ghione, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,368
Vincent Croglio, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $15,454
Steven Green, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,842